APO Research
Talk to an analyst

APO RESEARCH · REPORT

CCL14 Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global CCL14 Antibody Industry Growth and Trends Forecast to 2032

22 December 2025107 pages

Choose your research edition.

Industry ResearchCCL14 Antibody Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal CCL14 Antibody Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal CCL14 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CCL14 Antibody Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal CCL14 Antibody Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global CCL14 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for CCL14 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for CCL14 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CCL14 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of CCL14 Antibody include Thermo Fisher Scientific, Boster Biological Technology, Sino Biological, Inc., MyBiosource, Inc., LifeSpan BioSciences, Inc, Creative Diagnostics, Creative Biolabs, Cepham Life Sciences and Bio-Techne, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global CCL14 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The CCL14 Antibody market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CCL14 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CCL14 Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global CCL14 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

CCL14 Antibody Market by Company

Thermo Fisher Scientific

Boster Biological Technology

Sino Biological, Inc.

MyBiosource, Inc.

LifeSpan BioSciences, Inc

Creative Diagnostics

Creative Biolabs

Cepham Life Sciences

Bio-Techne

Biorbyt

Abbexa

​​Abcam

CCL14 Antibody Segment by Type

Monoclonal Antibody

Polyclonal Antibody

CCL14 Antibody Segment by Application

Western Blot

Flow Cytometry

ELISA

Immunoprecipitation

Immunofluorescence

Other

CCL14 Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CCL14 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CCL14 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CCL14 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of CCL14 Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of CCL14 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monoclonal Antibody Table 2. Major Company of Polyclonal Antibody Table 3. Global CCL14 Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global CCL14 Antibody Sales by Type (2021-2026) & (k units) Table 5. Global CCL14 Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global CCL14 Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global CCL14 Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global CCL14 Antibody Price by Type (2021-2026) & (US$/unit) Table 9. Global CCL14 Antibody Sales by Type (2027-2032) & (k units) Table 10. Global CCL14 Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global CCL14 Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global CCL14 Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global CCL14 Antibody Price by Type (2027-2032) & (US$/unit) Table 14. North America CCL14 Antibody Sales by Type (2021-2026) & (k units) Table 15. North America CCL14 Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe CCL14 Antibody Sales by Type (2021-2026) & (k units) Table 17. Europe CCL14 Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific CCL14 Antibody Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific CCL14 Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America CCL14 Antibody Sales by Type (2021-2026) & (k units) Table 21. Latin America CCL14 Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa CCL14 Antibody Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa CCL14 Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. CCL14 Antibody Industry Trends Table 25. CCL14 Antibody Industry Drivers Table 26. CCL14 Antibody Industry Opportunities and Challenges Table 27. CCL14 Antibody Industry Restraints Table 28. Global CCL14 Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global CCL14 Antibody Revenue Market Share by Company (2021-2026) Table 30. Global CCL14 Antibody Sales by Company (2021-2026) & (k units) Table 31. Global CCL14 Antibody Sales Share by Company (2021-2026) Table 32. Global CCL14 Antibody Market Price by Company (2021-2026) & (US$/unit) Table 33. Global CCL14 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global CCL14 Antibody Major Company Production Sites and Headquarters Table 35. Global CCL14 Antibody Company, Product Type & Application Table 36. Global CCL14 Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global CCL14 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global CCL14 Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global CCL14 Antibody Sales by Region (2021-2026) & (k units) Table 41. Global CCL14 Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global CCL14 Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global CCL14 Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global CCL14 Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global CCL14 Antibody Sales by Region (2027-2032) & (k units) Table 46. Global CCL14 Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global CCL14 Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global CCL14 Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global CCL14 Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global CCL14 Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global CCL14 Antibody Sales by Application (2021-2026) & (k units) Table 52. Global CCL14 Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global CCL14 Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global CCL14 Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global CCL14 Antibody Price by Application (2021-2026) & (US$/unit) Table 56. Global CCL14 Antibody Sales by Application (2027-2032) & (k units) Table 57. Global CCL14 Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global CCL14 Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global CCL14 Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global CCL14 Antibody Price by Application (2027-2032) & (US$/unit) Table 61. North America CCL14 Antibody Sales by Application (2021-2026) & (k units) Table 62. North America CCL14 Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe CCL14 Antibody Sales by Application (2021-2026) & (k units) Table 64. Europe CCL14 Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific CCL14 Antibody Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific CCL14 Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America CCL14 Antibody Sales by Application (2021-2026) & (k units) Table 68. Latin America CCL14 Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa CCL14 Antibody Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa CCL14 Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific CCL14 Antibody Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Boster Biological Technology Company Information Table 77. Boster Biological Technology Business Overview Table 78. Boster Biological Technology CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Boster Biological Technology CCL14 Antibody Product Portfolio Table 80. Boster Biological Technology Recent Development Table 81. Sino Biological, Inc. Company Information Table 82. Sino Biological, Inc. Business Overview Table 83. Sino Biological, Inc. CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sino Biological, Inc. CCL14 Antibody Product Portfolio Table 85. Sino Biological, Inc. Recent Development Table 86. MyBiosource, Inc. Company Information Table 87. MyBiosource, Inc. Business Overview Table 88. MyBiosource, Inc. CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. MyBiosource, Inc. CCL14 Antibody Product Portfolio Table 90. MyBiosource, Inc. Recent Development Table 91. LifeSpan BioSciences, Inc Company Information Table 92. LifeSpan BioSciences, Inc Business Overview Table 93. LifeSpan BioSciences, Inc CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. LifeSpan BioSciences, Inc CCL14 Antibody Product Portfolio Table 95. LifeSpan BioSciences, Inc Recent Development Table 96. Creative Diagnostics Company Information Table 97. Creative Diagnostics Business Overview Table 98. Creative Diagnostics CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Creative Diagnostics CCL14 Antibody Product Portfolio Table 100. Creative Diagnostics Recent Development Table 101. Creative Biolabs Company Information Table 102. Creative Biolabs Business Overview Table 103. Creative Biolabs CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Creative Biolabs CCL14 Antibody Product Portfolio Table 105. Creative Biolabs Recent Development Table 106. Cepham Life Sciences Company Information Table 107. Cepham Life Sciences Business Overview Table 108. Cepham Life Sciences CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Cepham Life Sciences CCL14 Antibody Product Portfolio Table 110. Cepham Life Sciences Recent Development Table 111. Bio-Techne Company Information Table 112. Bio-Techne Business Overview Table 113. Bio-Techne CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Bio-Techne CCL14 Antibody Product Portfolio Table 115. Bio-Techne Recent Development Table 116. Biorbyt Company Information Table 117. Biorbyt Business Overview Table 118. Biorbyt CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Biorbyt CCL14 Antibody Product Portfolio Table 120. Biorbyt Recent Development Table 121. Abbexa Company Information Table 122. Abbexa Business Overview Table 123. Abbexa CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Abbexa CCL14 Antibody Product Portfolio Table 125. Abbexa Recent Development Table 126. ​​Abcam Company Information Table 127. ​​Abcam Business Overview Table 128. ​​Abcam CCL14 Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. ​​Abcam CCL14 Antibody Product Portfolio Table 130. ​​Abcam Recent Development Table 131. North America CCL14 Antibody Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America CCL14 Antibody Sales by Country (2021-2026) & (k units) Table 133. North America CCL14 Antibody Sales Market Share by Country (2021-2026) Table 134. North America CCL14 Antibody Sales Forecast by Country (2027-2032) & (k units) Table 135. North America CCL14 Antibody Sales Market Share Forecast by Country (2027-2032) Table 136. North America CCL14 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America CCL14 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 138. North America CCL14 Antibody Market Share by Country (2021-2026) Table 139. North America CCL14 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America CCL14 Antibody Market Share Forecast by Country (2027-2032) Table 141. Europe CCL14 Antibody Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe CCL14 Antibody Sales by Country (2021-2026) & (k units) Table 143. Europe CCL14 Antibody Sales Market Share by Country (2021-2026) Table 144. Europe CCL14 Antibody Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe CCL14 Antibody Sales Market Share Forecast by Country (2027-2032) Table 146. Europe CCL14 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe CCL14 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe CCL14 Antibody Market Share by Country (2021-2026) Table 149. Europe CCL14 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe CCL14 Antibody Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific CCL14 Antibody Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific CCL14 Antibody Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific CCL14 Antibody Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific CCL14 Antibody Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific CCL14 Antibody Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific CCL14 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific CCL14 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific CCL14 Antibody Market Share by Country (2021-2026) Table 159. Asia-Pacific CCL14 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific CCL14 Antibody Market Share Forecast by Country (2027-2032) Table 161. Latin America CCL14 Antibody Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America CCL14 Antibody Sales by Country (2021-2026) & (k units) Table 163. Latin America CCL14 Antibody Sales Market Share by Country (2021-2026) Table 164. Latin America CCL14 Antibody Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America CCL14 Antibody Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America CCL14 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America CCL14 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America CCL14 Antibody Market Share by Country (2021-2026) Table 169. Latin America CCL14 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America CCL14 Antibody Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa CCL14 Antibody Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa CCL14 Antibody Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa CCL14 Antibody Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa CCL14 Antibody Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa CCL14 Antibody Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa CCL14 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa CCL14 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa CCL14 Antibody Market Share by Country (2021-2026) Table 179. Middle East and Africa CCL14 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa CCL14 Antibody Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. CCL14 Antibody Distributors List Table 184. CCL14 Antibody Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. CCL14 Antibody Image Figure 2. Global CCL14 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CCL14 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global CCL14 Antibody Sales (2021-2032) & (k units) Figure 5. Monoclonal Antibody Image Figure 6. Global Monoclonal Antibody Sales YoY Growth (2021-2032) & (k units) Figure 7. Polyclonal Antibody Image Figure 8. Global Polyclonal Antibody Sales YoY Growth (2021-2032) & (k units) Figure 9. Global CCL14 Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global CCL14 Antibody Market Share by Type 2025 VS 2032 Figure 11. North America CCL14 Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America CCL14 Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe CCL14 Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe CCL14 Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific CCL14 Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific CCL14 Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America CCL14 Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America CCL14 Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa CCL14 Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa CCL14 Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 CCL14 Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Western Blot Image Figure 24. Global Western Blot Sales YoY Growth (2021-2032) & (k units) Figure 25. Flow Cytometry Image Figure 26. Global Flow Cytometry Sales YoY Growth (2021-2032) & (k units) Figure 27. ELISA Image Figure 28. Global ELISA Sales YoY Growth (2021-2032) & (k units) Figure 29. Immunoprecipitation Image Figure 30. Global Immunoprecipitation Sales YoY Growth (2021-2032) & (k units) Figure 31. Immunofluorescence Image Figure 32. Global Immunofluorescence Sales YoY Growth (2021-2032) & (k units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 35. Global CCL14 Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global CCL14 Antibody Market Share by Application 2025 VS 2032 Figure 37. North America CCL14 Antibody Sales Market Share in Volume by Application in 2025 Figure 38. North America CCL14 Antibody Sales Market Share in Value by Application in 2025 Figure 39. Europe CCL14 Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Europe CCL14 Antibody Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific CCL14 Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific CCL14 Antibody Sales Market Share in Value by Application in 2025 Figure 43. Latin America CCL14 Antibody Sales Market Share in Volume by Application in 2025 Figure 44. Latin America CCL14 Antibody Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa CCL14 Antibody Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa CCL14 Antibody Sales Market Share in Value by Application in 2025 Figure 47. North America CCL14 Antibody Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America CCL14 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America CCL14 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe CCL14 Antibody Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe CCL14 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe CCL14 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific CCL14 Antibody Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific CCL14 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific CCL14 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America CCL14 Antibody Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America CCL14 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America CCL14 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa CCL14 Antibody Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa CCL14 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa CCL14 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa CCL14 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. CCL14 Antibody Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. CCL14 Antibody Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibody
  • Polyclonal Antibody
Applications
  • Western Blot
  • Flow Cytometry
  • ELISA
  • Immunoprecipitation
  • Immunofluorescence
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Boster Biological Technology
  • Sino Biological, Inc.
  • MyBiosource, Inc.
  • LifeSpan BioSciences, Inc
  • Creative Diagnostics
  • Creative Biolabs
  • Cepham Life Sciences
  • Bio-Techne
  • Biorbyt
  • Abbexa
  • ​​Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global CCL14 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global CCL14 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 CCL14 Antibody Market by Type
  6. 1.3.1 Monoclonal Antibody
  7. 1.3.2 Polyclonal Antibody
  8. 1.4 Global CCL14 Antibody Market Size by Type
  9. 1.4.1 Global CCL14 Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global CCL14 Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global CCL14 Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America CCL14 Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe CCL14 Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific CCL14 Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America CCL14 Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa CCL14 Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 CCL14 Antibody Industry Trends
  2. 2.2 CCL14 Antibody Industry Drivers
  3. 2.3 CCL14 Antibody Industry Opportunities and Challenges
  4. 2.4 CCL14 Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by CCL14 Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by CCL14 Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by CCL14 Antibody Price (2021-2026)
  4. 3.4 Global CCL14 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global CCL14 Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global CCL14 Antibody Company, Product Type & Application
  7. 3.7 Global CCL14 Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global CCL14 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 CCL14 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 CCL14 Antibody Tier 1, Tier 2, and Tier 3
4 CCL14 Antibody Regional Status and Outlook
  1. 4.1 Global CCL14 Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global CCL14 Antibody Historic Market Size by Region
  3. 4.2.1 Global CCL14 Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global CCL14 Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global CCL14 Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global CCL14 Antibody Forecasted Market Size by Region
  7. 4.3.1 Global CCL14 Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global CCL14 Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global CCL14 Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 CCL14 Antibody by Application
  1. 5.1 CCL14 Antibody Market by Application
  2. 5.1.1 Western Blot
  3. 5.1.2 Flow Cytometry
  4. 5.1.3 ELISA
  5. 5.1.4 Immunoprecipitation
  6. 5.1.5 Immunofluorescence
  7. 5.1.6 Other
  8. 5.2 Global CCL14 Antibody Market Size by Application
  9. 5.2.1 Global CCL14 Antibody Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global CCL14 Antibody Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global CCL14 Antibody Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America CCL14 Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe CCL14 Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific CCL14 Antibody Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America CCL14 Antibody Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa CCL14 Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific CCL14 Antibody Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Boster Biological Technology
  8. 6.2.1 Boster Biological Technology Company Information
  9. 6.2.2 Boster Biological Technology Business Overview
  10. 6.2.3 Boster Biological Technology CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boster Biological Technology CCL14 Antibody Product Portfolio
  12. 6.2.5 Boster Biological Technology Recent Developments
  13. 6.3 Sino Biological, Inc.
  14. 6.3.1 Sino Biological, Inc. Company Information
  15. 6.3.2 Sino Biological, Inc. Business Overview
  16. 6.3.3 Sino Biological, Inc. CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sino Biological, Inc. CCL14 Antibody Product Portfolio
  18. 6.3.5 Sino Biological, Inc. Recent Developments
  19. 6.4 MyBiosource, Inc.
  20. 6.4.1 MyBiosource, Inc. Company Information
  21. 6.4.2 MyBiosource, Inc. Business Overview
  22. 6.4.3 MyBiosource, Inc. CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MyBiosource, Inc. CCL14 Antibody Product Portfolio
  24. 6.4.5 MyBiosource, Inc. Recent Developments
  25. 6.5 LifeSpan BioSciences, Inc
  26. 6.5.1 LifeSpan BioSciences, Inc Company Information
  27. 6.5.2 LifeSpan BioSciences, Inc Business Overview
  28. 6.5.3 LifeSpan BioSciences, Inc CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LifeSpan BioSciences, Inc CCL14 Antibody Product Portfolio
  30. 6.5.5 LifeSpan BioSciences, Inc Recent Developments
  31. 6.6 Creative Diagnostics
  32. 6.6.1 Creative Diagnostics Company Information
  33. 6.6.2 Creative Diagnostics Business Overview
  34. 6.6.3 Creative Diagnostics CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Creative Diagnostics CCL14 Antibody Product Portfolio
  36. 6.6.5 Creative Diagnostics Recent Developments
  37. 6.7 Creative Biolabs
  38. 6.7.1 Creative Biolabs Company Information
  39. 6.7.2 Creative Biolabs Business Overview
  40. 6.7.3 Creative Biolabs CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Creative Biolabs CCL14 Antibody Product Portfolio
  42. 6.7.5 Creative Biolabs Recent Developments
  43. 6.8 Cepham Life Sciences
  44. 6.8.1 Cepham Life Sciences Company Information
  45. 6.8.2 Cepham Life Sciences Business Overview
  46. 6.8.3 Cepham Life Sciences CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cepham Life Sciences CCL14 Antibody Product Portfolio
  48. 6.8.5 Cepham Life Sciences Recent Developments
  49. 6.9 Bio-Techne
  50. 6.9.1 Bio-Techne Company Information
  51. 6.9.2 Bio-Techne Business Overview
  52. 6.9.3 Bio-Techne CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bio-Techne CCL14 Antibody Product Portfolio
  54. 6.9.5 Bio-Techne Recent Developments
  55. 6.10 Biorbyt
  56. 6.10.1 Biorbyt Company Information
  57. 6.10.2 Biorbyt Business Overview
  58. 6.10.3 Biorbyt CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Biorbyt CCL14 Antibody Product Portfolio
  60. 6.10.5 Biorbyt Recent Developments
  61. 6.11 Abbexa
  62. 6.11.1 Abbexa Company Information
  63. 6.11.2 Abbexa Business Overview
  64. 6.11.3 Abbexa CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Abbexa CCL14 Antibody Product Portfolio
  66. 6.11.5 Abbexa Recent Developments
  67. 6.12 ​​Abcam
  68. 6.12.1 ​​Abcam Company Information
  69. 6.12.2 ​​Abcam Business Overview
  70. 6.12.3 ​​Abcam CCL14 Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ​​Abcam CCL14 Antibody Product Portfolio
  72. 6.12.5 ​​Abcam Recent Developments
7 North America by Country
  1. 7.1 North America CCL14 Antibody Sales by Country
  2. 7.1.1 North America CCL14 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America CCL14 Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America CCL14 Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America CCL14 Antibody Market Size by Country
  6. 7.2.1 North America CCL14 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America CCL14 Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America CCL14 Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe CCL14 Antibody Sales by Country
  2. 8.1.1 Europe CCL14 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe CCL14 Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe CCL14 Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe CCL14 Antibody Market Size by Country
  6. 8.2.1 Europe CCL14 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe CCL14 Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe CCL14 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific CCL14 Antibody Sales by Country
  2. 9.1.1 Asia-Pacific CCL14 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific CCL14 Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific CCL14 Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific CCL14 Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific CCL14 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific CCL14 Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific CCL14 Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America CCL14 Antibody Sales by Country
  2. 10.1.1 South America CCL14 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America CCL14 Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America CCL14 Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America CCL14 Antibody Market Size by Country
  6. 10.2.1 South America CCL14 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America CCL14 Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America CCL14 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa CCL14 Antibody Sales by Country
  2. 11.1.1 Middle East and Africa CCL14 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa CCL14 Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa CCL14 Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa CCL14 Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa CCL14 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa CCL14 Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa CCL14 Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 CCL14 Antibody Value Chain Analysis
  2. 12.1.1 CCL14 Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 CCL14 Antibody Production Mode & Process
  7. 12.2 CCL14 Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 CCL14 Antibody Distributors
  10. 12.2.3 CCL14 Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst